CYP3A genotypes of donors but not those of the patients increase the risk of acute rejection in renal transplant recipients on calcineurin inhibitors: a pilot study.

Guillermo GervasiniGuadalupe García-PinoEsther VergaraSonia Mota-ZamoranoMontserrat García-CerradaEnrique Luna

Published in: European journal of clinical pharmacology (2017)

Our preliminary findings suggest that the determination of the CYP3A genotype of the donor, but not that of the recipient, may be useful to predict the incidence of acute rejection in renal transplantation.

Keyphrases

liver failure
end stage renal disease
respiratory failure
ejection fraction
drug induced
aortic dissection
peritoneal dialysis
risk factors